Tag

7 Oh

All articles tagged with #7 oh

DEA Targets Kratom's Potent Additive: Temporary Schedule I Plan for 7-OH
health8 days ago

DEA Targets Kratom's Potent Additive: Temporary Schedule I Plan for 7-OH

The DEA plans to temporarily place 7-OH, an opioid-like component of kratom, in Schedule I for two years (potentially extending to a third) for products above a certain threshold. Supporters say the move protects public health by curbing dependence and abuse, while critics question the science and warn it could hurt consumers who rely on kratom; the policy is framed as a win for the mainstream kratom industry amid political and lobbying dynamics.

Kratom Emerges as NY’s Worrying New Addiction Spike
health24 days ago

Kratom Emerges as NY’s Worrying New Addiction Spike

New York doctors warn that kratom, especially the potent 7-OH variant, is the leading new substance addiction seen at SPARC, with withdrawal and opioid-like effects; marketed as a natural remedy but unregulated federally and linked to overdoses. State action is tightening controls, including a 21+ purchase age, as treatment centers warn of easy access and rising cases.

Gas-station kratom 7-OH dubbed 'gas station heroin' sparks new opioid threat
health24 days ago

Gas-station kratom 7-OH dubbed 'gas station heroin' sparks new opioid threat

Laboratory analysis of a gas-station kratom pill revealed a potent, unlisted dose of 7-OH, an opioid-like chemical marketed as kratom and sold in gummies, drinks and even ice cream. The FDA says 7-OH could be the next wave of the opioid epidemic; CDC data link kratom to rising hospitalizations and deaths, especially when mixed with alcohol or other drugs. Because many products don’t disclose 7-OH on labels, consumers may not know what they’re taking. While some advocates push bans on 7-OH, others call for tighter labeling and professional guidance rather than outright prohibition.

Clarke’s Kratom Episode Pushes the Controversial Plant Into Regulatory Spotlight
health1 month ago

Clarke’s Kratom Episode Pushes the Controversial Plant Into Regulatory Spotlight

NBA forward Brandon Clarke’s Arkansas arrest over kratom capsules—he told deputies, 'it's just kratom'—highlights a fiercely debated, poorly regulated plant that critics say can be addictive and dangerous. With Tennessee and other states weighing bans, the FDA warns of serious risks, while Arkansas already criminalized kratom; Clarke later died in California, with toxicology results pending and officials not confirming kratom as a factor. The case underscores ongoing questions about kratom’s medical value, safety, and the integrity of industry practices and sponsorships in sports.

FDA and US officials target potent kratom products amid safety concerns
health11 months ago

FDA and US officials target potent kratom products amid safety concerns

The FDA is targeting 7-hydroxymitragynine (7-OH), a potent, morphine-like compound found in kratom, which has gained popularity for its pain-relieving and mood-enhancing effects. While some advocate for its benefits, concerns about its high potency, potential for addiction, and unregulated production have led to calls for stricter regulation to ensure safety. Kratom's legal status varies across states, and the compound's effects are not fully understood, raising public health concerns.

FDA Moves to Ban Gas Station and Kratom Products with Opioid-Like Effects
health11 months ago

FDA Moves to Ban Gas Station and Kratom Products with Opioid-Like Effects

The FDA is recommending regulatory action to control 7-hydroxymitragynine (7-OH), a potent opioid byproduct of the kratom plant, due to its abuse potential and presence in unregulated products, especially those appealing to youth. The agency emphasizes the risks and is working to prevent a new wave of opioid addiction by alerting healthcare professionals and consumers, and collaborating with the DEA for scheduling.